Mednax Other Non Cash Items from 2010 to 2024

MD Stock  USD 8.48  0.57  6.30%   
Mednax's Other Non Cash Items is increasing over the years with stable fluctuation. Overall, Other Non Cash Items is expected to go to about 165.5 M this year. During the period from 2010 to 2024 Mednax Other Non Cash Items annual values regression line had geometric mean of  9,240,888 and mean square error of 143662.5 T. View All Fundamentals
 
Other Non Cash Items  
First Reported
1995-12-31
Previous Quarter
-1.6 M
Current Value
163.2 M
Quarterly Volatility
151.6 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Mednax financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mednax main balance sheet or income statement drivers, such as Depreciation And Amortization of 34.2 M, Interest Expense of 24.4 M or Total Revenue of 1.5 B, as well as many exotic indicators such as Price To Sales Ratio of 0.37, Dividend Yield of 0.0 or PTB Ratio of 0.87. Mednax financial statements analysis is a perfect complement when working with Mednax Valuation or Volatility modules.
  
This module can also supplement Mednax's financial leverage analysis and stock options assessment as well as various Mednax Technical models . Check out the analysis of Mednax Correlation against competitors.

Latest Mednax's Other Non Cash Items Growth Pattern

Below is the plot of the Other Non Cash Items of Mednax Inc over the last few years. It is Mednax's Other Non Cash Items historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mednax's overall financial position and show how it may be relating to other accounts over time.
Other Non Cash Items10 Years Trend
Pretty Stable
   Other Non Cash Items   
       Timeline  

Mednax Other Non Cash Items Regression Statistics

Arithmetic Mean123,478,827
Geometric Mean9,240,888
Coefficient Of Variation303.63
Mean Deviation188,663,589
Median1,083,000
Standard Deviation374,919,943
Sample Variance140565T
Range1.5B
R-Value0.23
Mean Square Error143662.5T
R-Squared0.05
Significance0.42
Slope18,926,303
Total Sum of Squares1967909.5T

Mednax Other Non Cash Items History

2024165.5 M
2023157.6 M
202243.6 M
2021-27.8 M
202057.7 M
20191.5 B
2018-7.4 M

About Mednax Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Mednax income statement, its balance sheet, and the statement of cash flows. Mednax investors use historical funamental indicators, such as Mednax's Other Non Cash Items, to determine how well the company is positioned to perform in the future. Although Mednax investors may use each financial statement separately, they are all related. The changes in Mednax's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Mednax's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Mednax Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Mednax. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Non Cash Items157.6 M165.5 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Mednax Inc is a strong investment it is important to analyze Mednax's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mednax's future performance. For an informed investment choice regarding Mednax Stock, refer to the following important reports:
Check out the analysis of Mednax Correlation against competitors.
Note that the Mednax Inc information on this page should be used as a complementary analysis to other Mednax's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Complementary Tools for Mednax Stock analysis

When running Mednax's price analysis, check to measure Mednax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mednax is operating at the current time. Most of Mednax's value examination focuses on studying past and present price action to predict the probability of Mednax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mednax's price. Additionally, you may evaluate how the addition of Mednax to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Stocks Directory
Find actively traded stocks across global markets
Is Mednax's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mednax. If investors know Mednax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mednax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.31)
Revenue Per Share
24.265
Quarterly Revenue Growth
(0.03)
Return On Assets
0.0432
Return On Equity
(0.07)
The market value of Mednax Inc is measured differently than its book value, which is the value of Mednax that is recorded on the company's balance sheet. Investors also form their own opinion of Mednax's value that differs from its market value or its book value, called intrinsic value, which is Mednax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mednax's market value can be influenced by many factors that don't directly affect Mednax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mednax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mednax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mednax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.